Begrivac

国: ニュージーランド

言語: 英語

ソース: Medsafe (Medicines Safety Authority)

有効成分:

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug; Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug; Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug

から入手可能:

Novartis New Zealand Ltd

INN（国際名）:

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15 µg

投薬量:

0.5 mL

医薬品形態:

Suspension for injection

構図:

Active: Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug Excipient: Ether Formaldehyde Phosphate Buffered Saline Polymyxin B Polysorbate 80 Sucrose

パッケージ内のユニット:

Syringe, glass, Prefilled single 0.5ml dose, 1 dose unit

クラス:

Prescription

処方タイプ:

Prescription

製:

GSK Vaccines GmbH

製品概要:

Package - Contents - Shelf Life: Syringe, glass, Prefilled single 0.5ml dose - 1 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Syringe, glass, 0.5mL syringe, 10 pack - 10 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

承認日:

1999-11-12